Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome.

Meadows ME, Chang G, Jones JA, Antin JR, Orav EJ.

Arch Clin Neuropsychol. 2013 Jun;28(4):363-74. doi: 10.1093/arclin/acs141. Epub 2013 Feb 7.

2.

Mental status changes after hematopoietic stem cell transplantation.

Chang G, Meadows ME, Orav EJ, Antin JH.

Cancer. 2009 Oct 1;115(19):4625-35. doi: 10.1002/cncr.24496.

3.

Cognitive and other predictors of change in quality of life one year after treatment for chronic myelogenous leukemia or myelodysplastic syndrome.

Chang G, Meadows ME, Smallwood JA, Antin JH, Orav EJ.

J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):249-57. doi: 10.1176/appi.neuropsych.12070177.

PMID:
24817387
4.

Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.

Scherwath A, Schirmer L, Kruse M, Ernst G, Eder M, Dinkel A, Kunze S, Balck F, Bornhäuser M, Ehninger G, Dolan K, Gramatzki M, Kolb HJ, Heußner P, Wilhelm H, Beelen DW, Schulz-Kindermann F, Zander AR, Koch U, Mehnert A.

Psychooncology. 2013 Jul;22(7):1509-16. doi: 10.1002/pon.3159. Epub 2012 Sep 4.

PMID:
22945857
5.

Changes in cognitive functioning in the year after hematopoietic stem cell transplantation.

Jacobs SR, Small BJ, Booth-Jones M, Jacobsen PB, Fields KK.

Cancer. 2007 Oct 1;110(7):1560-7.

6.

Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS).

Chang G, Meadows ME, Jones JA, Antin JH, Orav EJ.

Am J Drug Alcohol Abuse. 2010 Jan;36(1):1-6. doi: 10.3109/00952990903490758.

7.

Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies.

Schulz-Kindermann F, Mehnert A, Scherwath A, Schirmer L, Schleimer B, Zander AR, Koch U.

Bone Marrow Transplant. 2007 Jun;39(12):789-99. Epub 2007 Apr 9.

PMID:
17417661
8.

Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.

Kobos R, Steinherz PG, Kernan NA, Prockop SE, Scaradavou A, Small TN, Shukla N, Khalaf R, O'Reilly RJ, Boulad F.

Biol Blood Marrow Transplant. 2012 Mar;18(3):473-80. doi: 10.1016/j.bbmt.2011.11.009. Epub 2011 Nov 10.

9.

Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.

Jim HS, Small B, Hartman S, Franzen J, Millay S, Phillips K, Jacobsen PB, Booth-Jones M, Pidala J.

Cancer. 2012 Jul 1;118(13):3407-16. doi: 10.1002/cncr.26645. Epub 2011 Dec 2.

10.

[Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].

Qin YZ, Li JL, Zhu HH, Ruan GR, Li LD, Zhang Y, Xu LP, Liu DH, Liu YR, Huang XJ, Chen SS, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2006 Aug;27(8):511-4. Chinese.

PMID:
17172121
11.

Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.

Baron F, Gothot A, Salmon JP, Hermanne JP, Pierard GE, Fillet G, Beguin Y.

Br J Haematol. 2000 Dec;111(3):745-53.

PMID:
11122133
12.

Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study.

Beglinger LJ, Duff K, Van Der Heiden S, Moser DJ, Bayless JD, Paulsen JS, Gingrich R.

J Int Neuropsychol Soc. 2007 Jan;13(1):172-7.

PMID:
17166316
13.

Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.

Koh H, Nakamae H, Hagihara K, Nakane T, Manabe M, Hayashi Y, Nishimoto M, Umemoto Y, Nakamae M, Hirose A, Inoue E, Inoue A, Yoshida M, Bingo M, Okamura H, Aimoto R, Aimoto M, Terada Y, Koh KR, Yamane T, Ohsawa M, Hino M.

J Exp Clin Cancer Res. 2011 Apr 10;30:36. doi: 10.1186/1756-9966-30-36.

14.

Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients.

Ditschkowski M, Elmaagacli AH, Trenschel R, Steckel NK, Koldehoff M, Beelen DW.

Clin Transplant. 2006 Jan-Feb;20(1):127-31.

PMID:
16556167
15.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
16.

Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.

Chodosh J, Seeman TE, Keeler E, Sewall A, Hirsch SH, Guralnik JM, Reuben DB.

J Am Geriatr Soc. 2004 Sep;52(9):1456-62.

PMID:
15341546
17.
18.

Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design.

Friedman MA, Fernandez M, Wefel JS, Myszka KA, Champlin RE, Meyers CA.

Arch Clin Neuropsychol. 2009 Nov;24(7):689-98. doi: 10.1093/arclin/acp060. Epub 2009 Sep 18.

PMID:
19767298
19.

Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.

Jones D, Vichaya EG, Wang XS, Sailors MH, Cleeland CS, Wefel JS.

Cancer. 2013 Dec 1;119(23):4188-95. doi: 10.1002/cncr.28323. Epub 2013 Sep 16.

20.

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.

Mittal P, Saliba RM, Giralt SA, Shahjahan M, Cohen AI, Karandish S, Onida F, Beran M, Champlin RE, de Lima M.

Bone Marrow Transplant. 2004 May;33(10):1005-9.

PMID:
15048141
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk